240 related articles for article (PubMed ID: 3637200)
41. Successful management of methicillin-resistant Staphylococcus aureus bacteremia unresponsive to Vancomycin by adding fosfomycin: a case report.
Linasmita P
J Med Assoc Thai; 2012 Jul; 95(7):960-3. PubMed ID: 22919993
[TBL] [Abstract][Full Text] [Related]
42. Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus.
del Río A; García-de-la-Mària C; Entenza JM; Gasch O; Armero Y; Soy D; Mestres CA; Pericás JM; Falces C; Ninot S; Almela M; Cervera C; Gatell JM; Moreno A; Moreillon P; Marco F; Miró JM;
Antimicrob Agents Chemother; 2016 Jan; 60(1):478-86. PubMed ID: 26525803
[TBL] [Abstract][Full Text] [Related]
43. In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
Unowsky J; Chandrasekar PH; DeLorenzo W; Levine DP
Chemotherapy; 1986; 32(6):499-505. PubMed ID: 3492342
[TBL] [Abstract][Full Text] [Related]
44. Fosfomycin enhances the expression of penicillin-binding protein 2 in methicillin-sensitive and methicillin-resistant Staphylococcus aureus strains.
Najioullah F; Pellon G; Freney J; Michel G; Fleurette J
FEMS Microbiol Lett; 1992 Oct; 76(3):221-6. PubMed ID: 1427011
[TBL] [Abstract][Full Text] [Related]
45. Treatment of infections due to methicillin-resistant Staphylococcus aureus.
Waldvogel FA
J Hosp Infect; 1986 Mar; 7 Suppl A():37-46. PubMed ID: 2871096
[No Abstract] [Full Text] [Related]
46. Epidemic of hospital-acquired infection due to methicillin-resistant Staphylococcus aureus in major Victorian hospitals.
Pavillard R; Harvey K; Douglas D; Hewstone A; Andrew J; Collopy B; Asche V; Carson P; Davidson A; Gilbert G; Spicer J; Tosolini F
Med J Aust; 1982 May; 1(11):451-4. PubMed ID: 7099074
[TBL] [Abstract][Full Text] [Related]
47. [Annual changes in isolation of MRSA in our department and chemotherapeutic effect of antibiotics including minocycline against postoperative infections of methicillin-resistant S. aureus].
Yokoyama T; Kodama T; Takesue Y; Fujimoto M; Murakami Y; Sewake H; Imamura Y; Okita M
Jpn J Antibiot; 1990 Jan; 43(1):131-8. PubMed ID: 2348549
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness of cefamandole against methicillin-resistant strains of Staphylococcus aureus in vitro and in experimental infections.
Hirschl A; Stanek G; Rotter M
J Antimicrob Chemother; 1984 May; 13(5):429-35. PubMed ID: 6735962
[TBL] [Abstract][Full Text] [Related]
49. The emergence of methicillin-resistant Staphylococcus aureus.
Wenzel RP
Ann Intern Med; 1982 Sep; 97(3):440-2. PubMed ID: 7114639
[No Abstract] [Full Text] [Related]
50. [Staphylococcus aureus resistant to cloxacillin: treatment with fosfomycin-rifampicin].
Wolff M; Nercelles P; Pepay K
Rev Med Chil; 1984 Jul; 112(7):665-71. PubMed ID: 6569621
[No Abstract] [Full Text] [Related]
51. [In vitro study of strains of Staphylococcus: choice of an antibiotic].
Messmer JC; Lecaillon-Thibon E; Soler H
Sem Hop; 1984 May; 60(19):1329-32. PubMed ID: 6326323
[TBL] [Abstract][Full Text] [Related]
52. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
Chambers HF; Hackbarth CJ; Drake TA; Rusnak MG; Sande MA
J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
[TBL] [Abstract][Full Text] [Related]
53.
Wang J; Xu X; Zhao X; Xu S; Wang M
Microb Drug Resist; 2023 Nov; 29(11):497-503. PubMed ID: 37603296
[TBL] [Abstract][Full Text] [Related]
54. [A case report of septicemia caused by methicillin cephem resistant Staphylococcus aureus (MRSA)].
Arakawa S; Takagi S; Matsui T; Maeda H; Ka S; Den S; Gohji K; Okada H; Matsumoto O; Kamidono S
Nihon Hinyokika Gakkai Zasshi; 1989 May; 80(5):728-31. PubMed ID: 2754897
[TBL] [Abstract][Full Text] [Related]
55. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Drugeon HB; Caillon J; Juvin ME
J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
[TBL] [Abstract][Full Text] [Related]
56. Methicillin-resistant Staphylococcus aureus.
Lifson A; Paul B
West J Med; 1984 Nov; 141(5):690. PubMed ID: 6569780
[No Abstract] [Full Text] [Related]
57. [Severe infections caused by methicillin-resistant Staphylococcus aureus. 62 cases].
May T; Janbon F; Beuscart C; Meyran M; Roue R
Presse Med; 1993 May; 22(19):909-13. PubMed ID: 8378281
[TBL] [Abstract][Full Text] [Related]
58. Therapeutic approach to methicillin-resistant Staphylococcus aureus (MRSA) infections: vancomycin update.
Gennery BA; Cooper GL
Br J Clin Pract Suppl; 1988 Feb; 57():100-1. PubMed ID: 3140867
[No Abstract] [Full Text] [Related]
59. Aerosolized vancomycin for treatment of airway colonization by methicillin-resistant Staphylococcus aureus.
Weathers L; Riggs D; Santeiro M; Weibley RE
Pediatr Infect Dis J; 1990 Mar; 9(3):220-1. PubMed ID: 2336303
[No Abstract] [Full Text] [Related]
60. Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: are there alternatives?
Milatovic D
Eur J Clin Microbiol; 1986 Dec; 5(6):689-92. PubMed ID: 3643105
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
